Skip to main content
Top
Published in: Critical Care 1/2004

01-02-2004 | Poster presentation

Study design of a mortality trial with intravenous levosimendan (the SURVIVE study) in patients with acutely decompensated heart failure

Authors: A Mebazaa, A Cohen-Solal, F Kleber, M Nieminen, M Packer, S Pocock, P Põder, T Sarapohja, M Kivikko

Published in: Critical Care | Special Issue 1/2004

Login to get access

Excerpt

Acutely decompensated heart failure (ADHF) represents the most severe form of heart failure with a short-term mortality approaching 30%. The SURVIVE study is the first prospective, randomised trial utilising mortality as the primary variable in evaluating the efficacy of intravenous drug therapy in ADHF. …
Metadata
Title
Study design of a mortality trial with intravenous levosimendan (the SURVIVE study) in patients with acutely decompensated heart failure
Authors
A Mebazaa
A Cohen-Solal
F Kleber
M Nieminen
M Packer
S Pocock
P Põder
T Sarapohja
M Kivikko
Publication date
01-02-2004
Publisher
BioMed Central
Published in
Critical Care / Issue Special Issue 1/2004
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/cc2554

Other articles of this Special Issue 1/2004

Critical Care 1/2004 Go to the issue